|
|
|
|
|
|
by alfon
1765 days ago
|
|
|
Any reason why this injection of OspA Monoclonal Antibodies wouldn't help in late disseminated Lyme disease?. My understanding is that very tough cases of neurological Lyme disease often benefit greatly from IVIG. Wouldn't this be a more targeted version of IVIG? |
|
|